Spotlight
What clinical research is changing right now — in plain language.
Learning
First spotlights are on their way.
Plain-language stories about trial results, the labs behind them, and the people taking part — curated by the Concord team. In the meantime, 2,265 trials are actively recruiting across Canada.
Newly added recruiting trials
RecruitingPHASE3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Asthma Control · Université de Sherbrooke
RecruitingNA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma · NRG Oncology
RecruitingPHASE3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis · Akero Therapeutics, Inc
RecruitingPHASE3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndromes · Takeda
RecruitingPHASE3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell · Merck Sharp & Dohme LLC
RecruitingPHASE3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Atopic Dermatitis · Pfizer
Where research is most active
Concord provides information support only. Trial listings come from public registries; nothing here is a claim about the efficacy of any treatment.